←
Rüegg Lab111 posts
Rüegg Lab avatar

Rüegg Lab

@RueggLab

Research Group of Prof. Markus A. Rüegg @biozentrum @UniBasel_en performing research on #Muscle Diseases #SkeletalMuscle #Aging #mTOR #LAMA2 #MDC1A #NMJ

◷ Joined May 2019▧ 37 Photos and videos
Rüegg Lab avatar
Rüegg Lab@RueggLab·Apr 21

Thank you for highlighting our study as Editor's choice, @MatrixBiology! We hope this work helps advance understanding of MTJ stability and its role in LAMA2-MD. doi.org/10.1016/j.matbio.202…

Post attachment

We are pleased to announce the first selection for the @MatrixBiology Editor’s Choice feature. “Laminin-α2 is required for the maintenance of the myotendinous junction in vivo” @JuliaSchedel, Shuo Lin, Thomas Bock, Dominik Burri, and Markus rüegg sciencedirect.com/science/ar…

Rüegg Lab avatar
Rüegg Lab@RueggLab·Feb 27

LAMA2-related muscular dystrophy is a rare genetic disease for which there is currently no treatment available. We are happy to share our recent publication in Molecular Therapy, where we describe a unique linker-mediated gene therapy approach . doi.org/10.1016/j.ymthe.2026…

Post attachment
Rüegg Lab avatar
Rüegg Lab@RueggLab·2 Dec 2025

We're delighted that two of our publications have been shortlisted among these great papers. If you enjoyed our work, you can vote with the link below:

It is that time again, time to vote for the 12th Annual Matt's Totally Biased (but less so) Top 10 Muscle Papers of the Year. Due to prohibitive shipping costs, this year’s winner will receive an e-gift card in lieu of a plaque. Voting will end Dec. 20. uab.co1.qualtrics.com/jfe/fo…

Post attachment
Rüegg Lab avatar
Rüegg Lab@RueggLab·28 Jun 2025

In our latest preprint, we show that activated muscle stem cells secrete laminin-α2 into their niche — and that the loss of this process intrinsically impairs their regenerative capacity in LAMA2-related muscular dystrophy: doi.org/10.1101/2025.06.23.6…

Post attachment
Biozentrum, University of Basel avatar
⟳ Rüegg Lab retweeted
Biozentrum, University of Basel@biozentrum·14 Apr 2025

New study by @RueggLab challenges previous view about the muscle growth factor #Myc! This protein is dispensable for #musclegrowth. High Myc levels disrupt muscle fiber structure and function. @UniBasel_en @snsf_ch @NatureComms ow.ly/mXQm50VzRkP

Rüegg Lab avatar
Rüegg Lab@RueggLab·4 Apr 2025

Myc and muscle growth: necessary in muscle stem cells, dispensable in muscle fibers and harmful if overexpressed. Check out our latest work rdcu.be/eggcw in @NatureComms, where we explore the role of Myc in muscle growth and more.

Post attachment
Rüegg Lab avatar
Rüegg Lab@RueggLab·27 Mar 2025

If you're using AAVs to develop a gene therapy or to study gene function in skeletal muscle, then this may be of interest to you. In our latest work, we show that AAVs commonly used to deliver transgenes to muscle fibers also target mononuclear cells: cell.com/molecular-therapy-f…

Rüegg Lab avatar
Rüegg Lab@RueggLab·6 Mar 2025

Check out our latest publication where we use single-nuclei RNA-seq to study gene expression at the neuromuscular junction: nature.com/articles/s41467-0… The paper also characterizes three novel NMJ proteins including the transcription factor ETV4 and the MuSK-binding protein PDZRN4.

Perrine Castets avatar
⟳ Rüegg Lab retweeted
Perrine Castets@PerrineCastets·23 May 2024

Really happy to share our study on Myotonic Dystrophy Type 1 now in #SkeletalMuscle. Very proud of the work performed by Denis Falcetta, @sandrinequirim, Florent Chabry, and all other group members and collaborators @unige @biozentrum. Thanks to all ! skeletalmusclejournal.biomed…

Rüegg Lab avatar
Rüegg Lab@RueggLab·17 May 2024

Check out our latest preprint where we use single-nuclei RNA-seq to study gene expression at the neuromuscular junction: biorxiv.org/content/10.1101/… The paper also characterizes three novel NMJ proteins including the Golgi-associated and MuSK-binding protein PDZRN4.

Post attachment
University of Basel avatar
⟳ Rüegg Lab retweeted
University of Basel@UniBasel_en·29 Feb 2024

On #RareDiseaseDay, we are putting the spotlight on LAMA2 muscular dystrophy. As yet, there are no effective therapies for this genetic disease. @SEAL_Tx, a @unibasel_en start-up, is now pursuing a promising approach. 🧵 1/7 unibas.ch/en/News-Events/New…